Quick Facts

• Chronic Constipation: A core application is the management of long-lasting constipation, promoting bowel movements.
• Hepatic Encephalopathy (HE): The medication is indicated for preventing and addressing this condition, which is associated with advanced liver disease, including the stages of hepatic pre-coma and coma.

---

Main Uses and Benefits

Нормолакт (lactulose) is a prescription-only medication primarily used to manage specific gastrointestinal and neurological conditions. Its established utility focuses on two main therapeutic domains.

For patients experiencing chronic constipation, the drug works to support an increase in the number of bowel movements and the frequency of days on which bowel movements occur. This action may help address discomfort and regulate intestinal function.

The second major clinical application is for the prevention and treatment of portal-systemic encephalopathy (PSE), often referred to as hepatic encephalopathy. In this context, the therapy is used as an adjunct to supportive care, aiming to support neurological function by working to reduce systemic levels of ammonia. The goal is to manage the symptoms of HE, which include changes in mental state.

Who Can and Cannot Use Нормолакт (Lactulose)

Official regulatory information defines specific populations eligible for treatment with Normolakt and those for whom use is strictly contraindicated.

Contraindications (Must Not Be Used)

Use of Normolakt is strictly prohibited in patients with certain pre-existing conditions:

• Galactosaemia, due to the drug's composition.
• Gastrointestinal obstruction, digestive perforation, or the risk of perforation.
• Acute inflammatory bowel diseases (such as Crohn's disease or ulcerative colitis).
• Painful abdominal syndromes of undetermined cause.

Eligibility by Age and Condition

Population/Condition	Eligibility Status (As per Label)
Adults and Adolescents	Approved for chronic constipation and Hepatic Encephalopathy (Adults only).
Children and Infants	Approved for chronic constipation only; use must be under medical supervision and is generally considered exceptional.
Pediatric Hepatic Encephalopathy (HE)	Safety and efficacy are not established.
Pregnancy and Lactation	Use is acceptable as the drug is negligibly absorbed systemically, meaning no effects are anticipated on the fetus or infant.
Diabetes Mellitus	Caution is advised, especially when using the high doses required for HE treatment.

Patients with renal or hepatic impairment (non-HE related) typically do not require special dosage recommendations.

The interaction profile for Нормолакт (Lactulose) is strictly defined by officially documented pharmacodynamic effects within the gastrointestinal tract and associated systemic risks.

Co-administration with nonabsorbable antacids may inhibit the desired reduction in colonic pH caused by Lactulose, which can result in a lack of therapeutic effect. Similarly, the pH reduction may lead to the inactivation or reduced efficacy of co-administered medicines whose release is pH-dependent in the colon, such as 5-aminosalicylic acid (5-ASA) compounds.

Another significant domain involves electrolytes. Concurrent use with agents that cause potassium loss, including thiazides, corticosteroids, and the antifungal Amphotericin B, may lead to an additive effect on potassium depletion, increasing the risk of hypokalemia. This condition of potassium deficiency can, in turn, enhance the toxicity and pharmacological effect of cardiac glycosides, such as Digoxin.

Regulatory documents place a specific constraint on co-administration with other laxatives, restricting their use during the initial management of portal-systemic encephalopathy (PSE). This rule prevents loose stools from falsely suggesting an adequate dosage has been achieved, which could mask the patient’s true therapeutic status. Furthermore, for elderly or debilitated patients receiving long-term treatment (six months or more), the documented risk of electrolyte disturbance mandates the periodic control of serum electrolytes.

The action of Lactulose is non-systemic, relying entirely on the local biochemical and physical environment of the colon. The mechanism is independent of human cellular receptors or enzymes, functioning primarily through a dual cascade: microbial metabolism and subsequent osmotic and chemical modulation.

Microbiota Metabolism and Osmotic Gradient

This domain covers the drug's role as a non-absorbed metabolic substrate for saccharolytic bacteria in the colon, which ferment it into Short-Chain Fatty Acids (SCFAs). The resulting increase in solute concentration—from both the original molecule and its metabolites—creates an osmotic gradient that draws water into the intestinal lumen. The influx of water increases stool volume and hydration, and the resultant bulk mechanically accelerates colonic peristalsis and reduces intestinal transit time.

pH-Dependent Ammonia Trapping

This mechanism is a result of the SCFAs produced during fermentation, which significantly lower the colonic pH. This acidic environment favors the chemical conversion of un-ionized, readily diffusible ammonia (NH3) into non-diffusible, charged ammonium ions (NH4^+). This ion-trapping mechanism limits the re-absorption of nitrogenous waste from the gut back into the systemic circulation.

Нормолакт (Lactulose solution) is a synthetic disaccharide used to treat chronic constipation and portal-systemic encephalopathy (PSE), a brain condition related to severe liver disease. Lactulose works as an osmotic agent, drawing water into the colon to soften stool and promote bowel movements. It is not absorbed into the body in significant amounts, with less than 3% excreted in the urine.

Administration Guidelines

• Measuring the Dose: Always measure the solution using the provided measuring cup, spoon, or oral syringe. Household spoons are not accurate for medication dosing.
• Ingestion: The solution can be taken undiluted or mixed with half a glass of liquid, such as water, milk, or fruit juice, to improve taste. Swallowing the dose quickly is recommended.
• Timing: Lactulose can be taken with or without food. Daily doses are often taken once a day, for example, at breakfast, or divided into two or three doses daily, as directed by a healthcare professional.

Constipation Dosing

The dosage must be adjusted individually to achieve a desired therapeutic effect, which is typically one to three soft stools per day. For adults, the usual starting dose is 15–45 mL daily. It may take 24 to 48 hours to achieve a bowel movement, as the drug must reach the colon to be effective.

Important Safety Note

During treatment with Lactulose, it is essential to maintain adequate fluid intake, equivalent to approximately six to eight glasses (about 2 liters) of water or other fluids daily. This helps prevent dehydration and supports the action of the laxative.

Research Evidence / Overview of Studies

Study Focus: Research Scope in Condition A

Research has explored whether the use of Drug X was related to an observation of fewer symptoms associated with Condition A. Initial randomized controlled trials (RCTs) primarily focused on patients newly diagnosed with moderate-to-severe forms of the condition.

Key Findings on Symptom Evaluation

Studies have evaluated this combination regarding reported pain levels in individuals with chronic Condition B. The primary endpoint in these trials was a score change on the Visual Analog Scale (VAS) for pain.

One meta-analysis demonstrated that researchers noted a change in quality of life scores after three months of treatment, as measured by the Condition-Specific Quality of Life Index (CSQLI).

Research Setting and Administration

Some studies used the drug at a specific time of day to examine research outcomes. Trial data has also explored whether dosage modifications influence the frequency of reported adverse events. Some research indicated the observed effect was more pronounced in individuals under 65.

Scope of Long-Term Data

A few studies explored the possibility of a relationship between the drug and the frequency of observed flare-ups. Long-term use was evaluated in clinical trials, with studies encompassing various patient profiles.

Research did not specifically examine the higher dosage in individuals with heart disease.

Some trials evaluated the drug's role in relation to how long or how intense acute symptoms were reported.

Exploratory Uses (Not Approved)

Findings show studies also examined the drug for management of Condition C, which is not an approved use. In these preliminary trials, the drug was often used in combination with standard care. This exploratory research is ongoing.

Key Studies & References Quality of Life Outcomes Following Treatment with Drug X: A Long-term Observational Study

Common questions about Нормолакт (FAQ)

---

Q: What should I do if I miss a dose of Normolact?

If a dose is forgotten, official guidance suggests that the missed dose be skipped. The next dose can then be taken at the usual time. It is not recommended to take two doses together to make up for a missed one.

---

Q: What is the concentration of the active ingredient in Normolact syrup?

Regulatory information specifies that the standard concentration of the solution is 10 g of lactulose in every 15 mL. This means that the syrup contains a high concentration of the active ingredient per volume.

---

Q: How long does a course of Normolact treatment usually last?

For common constipation, the treatment duration is typically short—often for up to a week. For more severe or chronic conditions, such as hepatic encephalopathy, official product information indicates that a healthcare professional may recommend taking it long-term, potentially for many months.

---

Q: Can I consume alcohol while taking Normolact?

Some brand formulations of lactulose may contain small amounts of ethanol (alcohol) as an excipient. This small amount is a factor that should be considered for individuals with a history of alcohol dependence, as well as for those who are pregnant, breastfeeding, or children.

---

Q: Is a special diet required while taking Normolact?

No special restrictive diet is typically necessary when using this medicine. However, regulatory warnings stress the importance of maintaining adequate fluid intake (often suggested as about 1.5 to 2 liters daily) to support the medication's osmotic action.

---

Q: Can Normolact cause diarrhea, and what should be done if it occurs?

Yes, regulatory documents list diarrhea as a very common side effect, especially when higher dosages are used. If diarrhea occurs, official information suggests consulting a healthcare provider about potentially decreasing the dosage. If fluid loss becomes extensive or persistent, it is important to seek medical assistance, as this carries a risk of electrolyte disturbances.

---

Q: Is there a risk that Normolact will flush beneficial nutrients from the body?

While the medicine itself is non-systemic, taking an excessive dose that results in persistent diarrhea carries a risk of fluid loss and electrolyte imbalances. Specifically, official warnings note the potential for hypokalemia, which is an abnormally low level of potassium.

---

Q: Does Normolact have a taste?

The solution is described as a clear, viscous liquid that ranges from colorless to pale brownish-yellow. Many users find the taste to be noticeably sweet, which is why official instructions permit mixing the dose with water or juice.

---

Q: Can Normolact be given to infants?

Lactulose is approved for use in infants, but official information emphasizes that its use in this age group should be considered exceptional and is recommended only under strict medical supervision. Regulatory information highlights a documented risk of dehydration and hyponatremia (low sodium) in infants receiving this treatment.

---

Q: After improvement, when can I stop taking Normolact?

For simple constipation, the course is often short, but the treatment can be taken for as long as the symptoms persist or as long as advised by a physician. The decision to stop treatment is ideally made with a healthcare professional, as it depends on the individual's clinical response and the specific condition being treated.

---

Q: What are the contraindications for taking Normolact?

Official regulatory documents strictly prohibit the use of this medicine in patients who have galactosaemia, gastrointestinal obstruction, or a condition involving a digestive perforation or the risk of one. It is also contraindicated in cases of painful abdominal syndromes when the cause has not been determined.

---

Q: Why is blood sugar control required for diabetics taking Normolact?

Caution is advised for diabetic patients because the solution contains small amounts of related sugars, such as galactose and fructose, as byproducts of the manufacturing process. However, the dose typically used for simple constipation is generally not expected to cause issues for most diabetics.

---

Q: How often should lab tests be performed during long-term use of Normolact?

Official product labeling advises that elderly or debilitated patients receiving the medicine for six months or longer should have their serum electrolyte levels periodically measured. This check includes monitoring potassium, chloride, and carbon dioxide levels.

---

Q: Is it safe to drive after taking Normolact?

According to official safety documents, lactulose has no or negligible influence on a person's ability to drive vehicles or operate heavy machinery.

---

Q: What is the maximum time I can take Normolact without consulting a doctor?

While the treatment duration for constipation can last up to a week, ongoing treatment is best guided by a physician. For chronic conditions, treatment often extends over many months. The total duration of use is managed in consultation with a healthcare professional.

---

Q: Is Normolact a brand-name drug or a generic?

Normolact is a brand formulation whose active ingredient is Lactulose. Lactulose itself is a non-proprietary, synthetic sugar that is available under numerous brand names and generic versions globally.

---

Q: Is a dose adjustment necessary for kidney or liver disease?

Official product information states that special dosage recommendations are not typically needed for patients with general kidney or liver impairment, as the medicine is negligibly absorbed into the bloodstream. This guidance excludes the specific use of high doses for hepatic encephalopathy (HE).

---

Q: Is it true that it changes the acidity in the intestine?

Yes, this is part of its mechanism of action. Official pharmacology data indicates that bacteria in the colon metabolize the lactulose into acids, which results in a measurable lowering of the pH (increased acidity) within the colon.

---

Q: Why is Normolact sometimes prescribed after surgery?

Although it is not an official approved indication, studies have examined the use of lactulose after surgical procedures. It is sometimes used in a clinical setting to treat or prevent constipation and to encourage the timely return of normal bowel movements post-operation.

---

Q: How can I tell if Normolact is not right for me?

Official safety warnings advise that if the medicine does not produce a sufficient therapeutic effect after several days, or if certain side effects like severe bloating (meteorism) occur and do not resolve, consultation with a physician is appropriate.

---

Q: What should I do if side effects from Normolact do not go away?

Common side effects like mild gas and abdominal cramps are generally temporary and tend to resolve spontaneously after the first few days of treatment. If symptoms persist, worsen, or if an unusual diarrheal condition occurs, it may be necessary to contact a physician.

---

Q: Is there a specific Normolact for children?

Lactulose is approved for use in children and infants. It is the same oral solution formulation used for adults, but it is administered in smaller, weight-adjusted doses. Official information emphasizes that its use in the pediatric population is recommended to be supervised by a medical professional.

Storage Requirements

Нормолакт (Lactulose solution) must be stored at controlled room temperature, specifically between 20^circC and 25^circC. The solution must be kept in a tight, light-resistant container and stored out of the reach of children. It is critical not to freeze the solution, and prolonged exposure above 30^circC must be avoided. After the bottle is opened, the solution should be used within 12 months to ensure stability. Users should not use the product if extreme darkening or cloudiness occurs.

Disposal Instructions

Any unused or expired Normolact must be disposed of in accordance with local requirements for pharmaceutical waste. Do not discard the solution in household trash or wastewater unless specifically instructed to do so by local regulations.